A quality defect was identified: potential presence of visible particles in solvent ampoules of a product intended for preparation of an injectable solution. Potential effects: complications after intravenous administration, embolism, inflammatory reactions, lack of treatment safety.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Tranxene 20 from batches A7165, A8171 and A8180; if in possession, return it to the pharmacy and consult a doctor in case of any doubts.
The Chief Pharmaceutical Inspector withdrew Tranxene 20 batches A7165, A8171 and A8180 from the market throughout Poland, granted the decision immediate enforceability, and obliged the marketing autho...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related